Glucokinase Regulatory Protein as a Putative Target for Gestational Diabetes Mellitus and Related Complications: Evidence From the Mendelian Randomization Study
This study provided novel evidence that circulating GCKR levels are causally implicated in GDM and related complications, suggesting that it may be a promising target for treatment.
Authors
- Jun Liu (ORCID: https://orcid.org/0000-0002-3646-0004)
- Shuai Yuan (ORCID: https://orcid.org/0000-0001-5055-5627)
- Yan Shen (ORCID: https://orcid.org/0000-0003-1650-9082)
- Yue Zhao (ORCID: https://orcid.org/0000-0001-8983-0024)
- Liangshan Mu (ORCID: https://orcid.org/0000-0003-2498-3825)
- Lin Wang (ORCID: https://orcid.org/0000-0002-6449-4930)
- Xiao Wang (ORCID: https://orcid.org/0000-0002-8652-8820)
- Kai Chen (ORCID: https://orcid.org/0000-0001-6850-1723)
- Yan Li (ORCID: https://orcid.org/0000-0001-8955-4082)
- Haiyan Yang
- Guiquan Wang (ORCID: https://orcid.org/0000-0002-6434-1627)
- Weian Mao
- Xi Dong
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Xiamen University (CN)
- Peking University (CN)
- Fudan University (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Karolinska Institutet (SE)
- University of Oxford (GB)
- Zhongshan Hospital (CN)
- Peking University Third Hospital (CN)
- Beijing Obstetrics and Gynecology Hospital (CN)
Publication Details
- Journal
- Journal of Diabetes
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/1753-0407.70056
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Novo Nordisk
- National Key Research and Development Program of China